JP2012528190A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528190A5 JP2012528190A5 JP2012513260A JP2012513260A JP2012528190A5 JP 2012528190 A5 JP2012528190 A5 JP 2012528190A5 JP 2012513260 A JP2012513260 A JP 2012513260A JP 2012513260 A JP2012513260 A JP 2012513260A JP 2012528190 A5 JP2012528190 A5 JP 2012528190A5
- Authority
- JP
- Japan
- Prior art keywords
- igg
- ultrafiltration
- ultrafiltration membrane
- diafiltration
- ultra
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18160609P | 2009-05-27 | 2009-05-27 | |
| US61/181,606 | 2009-05-27 | ||
| PCT/US2010/036430 WO2010138736A2 (en) | 2009-05-27 | 2010-05-27 | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528190A JP2012528190A (ja) | 2012-11-12 |
| JP2012528190A5 true JP2012528190A5 (https=) | 2013-07-11 |
| JP5341252B2 JP5341252B2 (ja) | 2013-11-13 |
Family
ID=42335649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513260A Active JP5341252B2 (ja) | 2009-05-27 | 2010-05-27 | 皮下使用の高濃度免疫グロブリン製剤を生成する方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US8546548B2 (https=) |
| EP (3) | EP2762492A3 (https=) |
| JP (1) | JP5341252B2 (https=) |
| KR (1) | KR101464032B1 (https=) |
| CN (1) | CN102459331B (https=) |
| AR (1) | AR076607A1 (https=) |
| AU (6) | AU2010253830B2 (https=) |
| BR (1) | BRPI1012082B1 (https=) |
| CA (1) | CA2763138A1 (https=) |
| CL (2) | CL2011002996A1 (https=) |
| CO (1) | CO6480954A2 (https=) |
| EA (1) | EA023382B1 (https=) |
| HK (1) | HK1200843A1 (https=) |
| MX (1) | MX2011012576A (https=) |
| MY (1) | MY157239A (https=) |
| SG (1) | SG176256A1 (https=) |
| TW (1) | TWI445714B (https=) |
| WO (1) | WO2010138736A2 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI489994B (zh) | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
| MX2011012576A (es) * | 2009-05-27 | 2012-05-08 | Baxter Int | Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo. |
| MX346115B (es) | 2009-08-06 | 2017-03-08 | Genentech Inc * | Metodo para mejorar la eliminación de virus en la purificacion proteica. |
| MX2012003282A (es) | 2009-09-17 | 2012-04-30 | Baxter Healthcare Sa | Co-formulacion estable de hialuronidasa e inmunoglobulina, y metodos de su uso. |
| US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
| WO2011150284A2 (en) | 2010-05-26 | 2011-12-01 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
| AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
| FR2962650B1 (fr) * | 2010-07-19 | 2013-04-05 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
| CA2810731A1 (en) | 2010-09-17 | 2012-03-22 | Baxter International Inc. | Stabilization of immunoglobulins and other proteins through aqueous formulation with sodium chloride at weak acidic to neutral ph |
| FR2974301B1 (fr) | 2011-04-20 | 2013-08-23 | Lab Francais Du Fractionnement | Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes |
| FR2977893B1 (fr) * | 2011-07-11 | 2015-02-20 | Lab Francais Du Fractionnement | Procede de preparation d'un concentre d'immunoglobulines polyvalentes |
| US9403899B2 (en) | 2011-08-26 | 2016-08-02 | Baxalta Incorporated | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
| DK2758076T3 (en) | 2011-09-24 | 2019-04-01 | Csl Behring Gmbh | COMBINATION THERAPY USING IMMUNOGLOBULIN AND C1 INHIBITOR |
| AU2012321074B2 (en) | 2011-12-13 | 2015-12-03 | Takeda Pharmaceutical Company Limited | Measurement of autoantibodies at low conductivity conditions with increased sensitivity |
| CN102532307B (zh) * | 2012-02-22 | 2013-06-12 | 成都蓉生药业有限责任公司 | 一种制备人免疫球蛋白的方法 |
| TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱 |
| EP2873422A4 (en) * | 2012-07-10 | 2015-12-30 | Takeda Pharmaceutical | PHARMACEUTICAL PREPARATION FOR INJECTION |
| US20150210753A1 (en) | 2012-07-26 | 2015-07-30 | Momenta Pharmaceuticals, Inc. | Glycoproteins with anti-inflammatory properties |
| CA2901225C (en) | 2013-03-08 | 2023-09-19 | Csl Behring Gmbh | Treatment and prevention of remote ischemia-reperfusion injury |
| AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| WO2014186310A1 (en) | 2013-05-13 | 2014-11-20 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
| EP3058084A4 (en) | 2013-10-16 | 2017-07-05 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
| MX380902B (es) * | 2013-11-15 | 2025-03-12 | Genentech Inc | Métodos para la inactivación viral usando detergentes ecológico. |
| CN108026507A (zh) * | 2015-04-02 | 2018-05-11 | K·黄 | 由组分vi制造afod静脉注射剂的方法 |
| WO2016196070A1 (en) | 2015-06-03 | 2016-12-08 | Children's Hospital Medical Center | Compositions and methods for treating neonatal biliary atresia |
| US11186858B1 (en) | 2016-03-15 | 2021-11-30 | Fresenius Kabi Deutschland Gmbh | Methods for increasing biosimilarity |
| EP3275897A1 (en) * | 2016-07-27 | 2018-01-31 | Biotest AG | Process for preparing immunoglobulin compositions |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| MX2020004151A (es) | 2017-10-30 | 2020-08-13 | Takeda Pharmaceuticals Co | Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos. |
| FR3081328B1 (fr) * | 2018-05-24 | 2021-01-01 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
| KR102337683B1 (ko) * | 2018-09-21 | 2021-12-13 | 주식회사 녹십자 | 고효율 항-tfpi 항체 조성물 |
| EP3955962A4 (en) * | 2019-04-18 | 2022-12-14 | Momenta Pharmaceuticals, Inc. | SIALYLATED GLYCOPROTEINS |
| EP4490179A1 (en) | 2022-03-07 | 2025-01-15 | Takeda Pharmaceutical Company Limited | Affinity chromatographic production of clinical human igg products |
| CN117069836B (zh) * | 2023-09-22 | 2024-08-27 | 武汉中生毓晋生物医药有限责任公司 | 一种抗人t细胞兔免疫球蛋白的制备方法 |
| WO2025068923A2 (en) * | 2023-09-26 | 2025-04-03 | Takeda Pharmaceutical Company Limited | IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE348942B (https=) | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
| US4136094A (en) * | 1977-08-31 | 1979-01-23 | The Regents Of The University Of Minnesota | Preparation of intravenous human and animal gamma globulins and isolation of albumin |
| DK166763B1 (da) | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
| DE3929411A1 (de) | 1988-09-22 | 1990-03-29 | Siegfried Natterer | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung |
| US4892826A (en) | 1988-10-11 | 1990-01-09 | Abbott Laboratories | Process for the preparation of urokinase derivatives |
| US4897465A (en) | 1988-10-12 | 1990-01-30 | Abbott Laboratories | Enrichment and concentration of proteins by ultrafiltration |
| JP2871709B2 (ja) | 1988-11-21 | 1999-03-17 | 住友製薬株式会社 | 免疫グロブリンｇ結合活性を有する新規な蛋白質プロテインｈ、該蛋白質をコードする遺伝子及び該蛋白質の製造法 |
| US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
| AT402261B (de) | 1991-01-25 | 1997-03-25 | Immuno Ag | Komplex enthaltend den gerinnungsfaktor ix |
| FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
| GB9418092D0 (en) * | 1994-09-08 | 1994-10-26 | Red Cross Found Cent Lab Blood | Organic compounds |
| TW491855B (en) | 1996-08-07 | 2002-06-21 | Csl Ltd | Purification of immunoglobulins |
| US5886154A (en) * | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
| AT405739B (de) | 1997-09-19 | 1999-11-25 | Immuno Ag | Verfahren zur reinigung von antithrombin iii |
| US20020114802A1 (en) | 1998-02-10 | 2002-08-22 | Tjellstrom Bo Arthur Einar | Oral immunoglobulin treatment for inflammatory bowel disease |
| DK2270044T3 (en) * | 1998-06-09 | 2015-01-26 | Csl Behring Ag | Liquid immunoglobulin G (IgG) product |
| NZ509135A (en) * | 1998-06-09 | 2002-10-25 | Statens Seruminstitut | A third generation intravenous immunoglobulin G (IVIG) purified using column chromatographic ion exchange methods |
| AUPQ026799A0 (en) * | 1999-05-10 | 1999-06-03 | Csl Limited | Method of increasing protein stability by removing immunoglobulin aggregates |
| SE0001128D0 (sv) | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
| US20020098182A1 (en) | 2000-09-28 | 2002-07-25 | Richard Weisbart | Treatment of immune-mediated diseases by oral administration of plasma fractions enriched in immunoglobulin G |
| FR2824568B1 (fr) | 2001-05-11 | 2004-04-09 | Lab Francais Du Fractionnement | Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique |
| GB0113179D0 (en) * | 2001-05-31 | 2001-07-25 | Novartis Ag | Organic compounds |
| CA2462682A1 (en) | 2001-10-04 | 2003-04-10 | Protein Therapeutics, Inc. | The use of gammaglobulin for the treatment of immune-mediated diseases |
| WO2005023867A1 (en) | 2003-09-08 | 2005-03-17 | Medical Research Council | Method for the treatment or prophylaxis of tuberculosis |
| JP2008500959A (ja) * | 2004-01-30 | 2008-01-17 | スオメン プナイネン リスティ ヴェリパルヴェル | ウイルスについて安全な免疫グロブリンの製造方法 |
| CN1922207B (zh) | 2004-02-27 | 2012-06-06 | 奥克特珐玛股份有限公司 | 提供纯化的、病毒安全的抗体制剂的方法 |
| US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| AU2008286361B2 (en) | 2007-08-13 | 2013-09-26 | Takeda Pharmaceutical Company Limited | IVIG modulation of chemokines for treatment of multiple sclerosis, Alzheimer's disease, and Parkinson's disease |
| CN101279246B (zh) * | 2007-12-28 | 2011-07-27 | 华侨大学 | 一种嗜硫性磁性复合微球的制备方法和用此复合微球分离免疫球蛋白g的方法 |
| ES2406029T3 (es) | 2008-04-15 | 2013-06-05 | Grifols Therapeutics Inc. | Ultrafiltración/diafiltración en dos fases |
| MX2011012576A (es) * | 2009-05-27 | 2012-05-08 | Baxter Int | Metodo para producir una preparacion altamente concentrada de inmunoglobulina de uso subcutaneo. |
-
2010
- 2010-05-27 MX MX2011012576A patent/MX2011012576A/es active IP Right Grant
- 2010-05-27 SG SG2011087566A patent/SG176256A1/en unknown
- 2010-05-27 CN CN201080032613.3A patent/CN102459331B/zh active Active
- 2010-05-27 EP EP14162703.4A patent/EP2762492A3/en not_active Withdrawn
- 2010-05-27 BR BRPI1012082-3A patent/BRPI1012082B1/pt active IP Right Grant
- 2010-05-27 AU AU2010253830A patent/AU2010253830B2/en active Active
- 2010-05-27 US US12/789,345 patent/US8546548B2/en active Active
- 2010-05-27 CA CA2763138A patent/CA2763138A1/en not_active Abandoned
- 2010-05-27 EP EP10722883A patent/EP2435474A2/en not_active Withdrawn
- 2010-05-27 MY MYPI2011005708A patent/MY157239A/en unknown
- 2010-05-27 EA EA201171481A patent/EA023382B1/ru not_active IP Right Cessation
- 2010-05-27 AR ARP100101845A patent/AR076607A1/es active IP Right Grant
- 2010-05-27 TW TW099117121A patent/TWI445714B/zh active
- 2010-05-27 KR KR1020117030990A patent/KR101464032B1/ko active Active
- 2010-05-27 WO PCT/US2010/036430 patent/WO2010138736A2/en not_active Ceased
- 2010-05-27 JP JP2012513260A patent/JP5341252B2/ja active Active
- 2010-05-27 EP EP19198667.8A patent/EP3708581A3/en active Pending
-
2011
- 2011-11-25 CL CL2011002996A patent/CL2011002996A1/es unknown
- 2011-12-27 CO CO11179041A patent/CO6480954A2/es not_active Application Discontinuation
-
2013
- 2013-06-11 CL CL2013001673A patent/CL2013001673A1/es unknown
- 2013-07-24 US US13/949,565 patent/US9175068B2/en active Active
-
2015
- 2015-02-04 HK HK15101161.4A patent/HK1200843A1/en unknown
- 2015-09-16 US US14/855,686 patent/US10125189B2/en active Active
-
2016
- 2016-05-30 AU AU2016203542A patent/AU2016203542B2/en active Active
-
2018
- 2018-01-23 AU AU2018200548A patent/AU2018200548B2/en active Active
- 2018-11-13 US US16/188,839 patent/US11242380B2/en active Active
-
2020
- 2020-06-25 AU AU2020204244A patent/AU2020204244B2/en active Active
-
2022
- 2022-01-31 US US17/589,519 patent/US20220153823A1/en active Pending
- 2022-09-07 AU AU2022228125A patent/AU2022228125B2/en active Active
-
2024
- 2024-05-29 AU AU2024203600A patent/AU2024203600A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012528190A5 (https=) | ||
| CA2941232C (en) | Method for purifying immunoglobulin | |
| RU2603347C2 (ru) | Очистка белка с использованием бис-трис буфера | |
| ES2959234T3 (es) | Procedimiento para preparar una composición de IgG enriquecida a partir de plasma | |
| RU2337109C2 (ru) | ПРЕПАРАТ ИММУНОГЛОБУЛИНА IgG И СПОСОБ ЕГО ПОЛУЧЕНИЯ | |
| CA2941230C (en) | Method for purifying immunoglobulin | |
| JP2013527201A5 (https=) | ||
| JP2008500959A (ja) | ウイルスについて安全な免疫グロブリンの製造方法 | |
| CA3080108C (en) | Improved method for purification of immunoglobulin | |
| CA2796409A1 (en) | Process for preparing an immunoglobulin composition | |
| CN104245730A (zh) | 源自血浆的免疫球蛋白的级分i-iv-1沉淀 | |
| ITFI20090273A1 (it) | Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale. | |
| JP2023532473A (ja) | ヒト血漿由来免疫グロブリンｍを含む組成物を得るための方法 | |
| CN102532307A (zh) | 一种制备人免疫球蛋白的方法 | |
| CN107849086A (zh) | 源自血浆的乙型肝炎人免疫球蛋白的制备方法 | |
| CN111944043B (zh) | 一种从血浆废弃物中提取IgM的方法 | |
| JP2025512143A (ja) | 酸化ケイ素吸着を使用する血漿からのｆｖｉｉｉの精製 | |
| JP2025514479A5 (https=) | ||
| TW388763B (en) | Method of producing a hyper immunoglobulin preparation from fractions produced druing fractionation of human blood plasma | |
| KR20230148961A (ko) | 면역글로불린 정제방법 | |
| KR102372105B1 (ko) | 면역글로블린의 제조방법 |